Zyphars Pharmaceutics

Zyphars Pharmaceutics is an Indian pharmaceutical company established in 2006, specializing in the manufacturing and marketing of high-quality branded generic formulations. The company focuses on critical care, cardiology, neurology, and oncology, providing a portfolio of over 100 products to more than 40 countries worldwide. Key products include life-saving antibiotics like Zypenem (meropenem) and Tigebid (tigecycline), as well as specialized treatments like Febalgan (pediatric paracetamol) and Neuroline. Zyphars operates with a strong emphasis on quality and affordability, maintaining ISO-certified and cGMP-compliant manufacturing facilities. The company has emerged as a preferred global supplier for pharmaceutical products in emerging markets across Asia, Africa, and Latin America.